Fingerprint
Dive into the research topics of 'Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Two phase 3 multicenter, randomized, double-blind, placebo-controlled studies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically